Chugai Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥294.67B ¥327.16B ¥326.11B ¥344.81B ¥326.94B ¥428.95B ¥379.51B ¥373.52B ¥391.22B ¥423.65B ¥461.11B ¥498.84B ¥491.78B ¥534.20B ¥579.79B ¥686.18B ¥786.95B ¥999.76B ¥1.26T ¥1.11T ¥0.00M
GM % Gross Margin %
62.29% 63.26% 59.08% 60.18% 60.56% 55.04% 57.20% 57.83% 57.13% 55.91% 52.95% 51.84% 49.58% 52.42% 54.66% 61.22% 65.25% 66.18% 62.20% 62.81% 0.00%
OM Operating Margin
17.48% 23.96% 17.78% 19.34% 15.19% 19.26% 17.45% 16.71% 19.53% 19.02% 16.89% 17.40% 15.63% 18.52% 21.44% 30.69% 38.28% 42.20% 42.33% 39.52% 0.00%
EPS Earnings Per Share
¥0.00
Div. Dividends
¥6.00 ¥11.33 ¥10.00 ¥10.00 ¥11.33 ¥13.33 ¥13.33 ¥13.33 ¥13.33 ¥15.00 ¥16.00 ¥19.33 ¥17.33 ¥20.67 ¥28.67 ¥46.67 ¥55.00 ¥76.00 ¥78.00 ¥80.00 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
1639.77m 1652.99m 1662.32m 1634.36m 1634.53m 1632.5m 1632.59m 1632.58m 1632.67m 1633.93m 1635.79m 1,638m 1638.69m 1639.95m 1641.58m 1642.37m 1643.82m 1644.21m 1644.26m 0m 1645.31m
OCF Operating Cash Flow
¥51.50B ¥64.66B ¥40.54B ¥60.36B ¥39.28B ¥66.46B ¥15.57B ¥69.59B ¥77.30B ¥53.52B ¥37.03B ¥62.92B ¥38.79B ¥107.62B ¥119.07B ¥206.64B ¥205.04B ¥279.63B ¥244.11B ¥409.93B ¥0.00M
FCF Free Cash Flow
¥39.75B ¥55.56B ¥19.22B ¥37.77B ¥14.05B ¥50.39B ¥2.01B ¥58.36B ¥62.25B ¥41.93B ¥20.80B ¥44.55B ¥8.70B ¥74.74B ¥47.29B ¥153.63B ¥148.00B ¥213.66B ¥181.49B ¥337.98B ¥0.00M
FCFS Free Cash Flow Per Share
¥24.18 ¥33.50 ¥11.56 ¥23.01 ¥8.60 ¥30.85 ¥1.23 ¥35.75 ¥38.13 ¥23.60 ¥10.93 ¥23.26 ¥1.50 ¥38.76 ¥25.23 ¥88.58 ¥87.41 ¥125.75 ¥105.10 ¥213.24 ¥0.00